CWM
IBB icon

Cabot Wealth Management’s iShares Biotechnology ETF IBB Stock Holding History

Cabot Wealth Management’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-2,320
Closed -$354K – 169
2021
Q4 		$354K Hold
2,320
– – 0.04% 133
2021
Q3 		$375K Hold
2,320
– – 0.05% 127
2021
Q2 		$380K Sell
2,320
-79
-3% -$12.2K 0.05% 125
2021
Q1 		$361K Sell
2,399
-38
-2% -$6.04K 0.05% 124
2020
Q4 		$369K Hold
2,437
– – 0.06% 118
2020
Q3 		$330K Buy
+2,437
New +$331K 0.06% 113
2018
Q1 		– Sell
-2,103
Closed -$225K – 130
2017
Q4 		$225K Sell
2,103
-240
-10% -$25.7K 0.05% 126
2017
Q3 		$261K Sell
2,343
-63
-3% -$6.73K 0.06% 118
2017
Q2 		$249K Sell
2,406
-189
-7% -$18.6K 0.06% 121
2017
Q1 		$254K Sell
2,595
-303
-10% -$29K 0.06% 124
2016
Q4 		$256K Sell
2,898
-3,723
-56% -$339K 0.07% 128
2016
Q3 		$639K Sell
6,621
-675
-9% -$64.2K 0.16% 102
2016
Q2 		$626K Sell
7,296
-1,242
-15% -$111K 0.16% 101
2016
Q1 		$742K Sell
8,538
-720
-8% -$64.4K 0.21% 91
2015
Q4 		$1.04M Buy
9,258
+45
+0.5% +$4.88K 0.27% 94
2015
Q3 		$932K Buy
9,213
+777
+9% +$93.2K 0.26% 89
2015
Q2 		$1.04M Sell
8,436
-855
-9% -$102K 0.25% 93
2015
Q1 		$1.06M Sell
9,291
-69
-0.7% -$7.61K 0.26% 95
2014
Q4 		$946K Sell
9,360
-1,035
-10% -$101K 0.23% 98
2014
Q3 		$948K Sell
10,395
-1,110
-10% -$97.4K 0.24% 103
2014
Q2 		$986K Sell
11,505
-246
-2% -$19.4K 0.25% 98
2014
Q1 		$926K Sell
11,751
-315
-3% -$26.2K 0.24% 107
2013
Q4 		$913K Sell
12,066
-3,108
-20% -$221K 0.24% 114
2013
Q3 		$1.06M Buy
15,174
+4,986
+49% +$327K 0.32% 105
2013
Q2 		$590K Buy
+10,188
New +$589K 0.2% 133

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Cabot Wealth Management's IBB Position: Q1 2022 in Review

Cabot Wealth Management sold out of iShares Biotechnology ETF (IBB) in Q1 2022, closing a stake of 2,320 shares — an estimated $354K sold.

Cabot Wealth Management first reported a position in IBB in Q2 2013 and held it in 25 quarters. The position peaked at $1.06M in Q1 2015. 897 funds tracked by Wall St. Rank hold IBB as of Q1 2022.

  • Cabot Wealth Management reported no remaining iShares Biotechnology ETF position as of Q1 2022 after selling out during the quarter.
  • Cabot Wealth Management sold 2,320 iShares Biotechnology ETF shares in Q1 2022, an estimated $354K.
  • Cabot Wealth Management first reported a position in iShares Biotechnology ETF in Q2 2013 and held it in 25 quarters.
  • Cabot Wealth Management's iShares Biotechnology ETF position peaked at $1.06M in Q1 2015.
  • 897 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2022.

Based on Cabot Wealth Management's 13F filing for Q1 2022, filed 14 Apr 2022.